Heartsciences ceo to participate in the benzinga all access event on july 15th

Southlake, texas, july 13, 2022 (globe newswire) -- heartsciences (nasdaq: hscs; hscsw)  (“company”), a medical technology company focused on applying innovative ai-based technology to an ecg (also known as an ekg) to significantly expand and improve an ecg's clinical usefulness, today announced that andrew simpson, ceo, and chairman of heartsciences, will be participating in the benzinga all access event taking place on july 15, 2022.
HSCS Ratings Summary
HSCS Quant Ranking